In mouse plasma degradation assay, the native peptide 1 had a half-life of 16 min and hybrids 2 , 5 and 9 had similar t 1/2 of 17, 23 and 17 min, respectively
While new research highlights how the use of Ozempic, Wegovy, and similar GLP-1 drugs for weight-loss management has risen dramatically, another study reveals that most users stop taking them within a year, raising questions about whether side effects of the medication have been adequately disclosed
We can tell you what tirzepatide really costs month after month why the price never stops what happens to your weight when you quit and an honest comparison to surgery that you will not find in the marketing
Anecdotal reports suggest people continuing treatment may lose an additional 2-5% over the next 24-48 weeks, but rate of loss becomes very slow
Emerging evidence suggests GLP-1RAs may help in: Alzheimer Disease Reduced neuroinflammation Improved neuronal survival Potential slowing of cognitive decline Parkinson Disease Neuroprotective effects Reduced oxidative stress Improved neuronal signaling This area may redefine future neuroendocrine therapeutics